Skip to main content
Top
Published in: International Journal of Legal Medicine 6/2008

01-11-2008 | Case Report

Acute fatal poisoning with pilsicainide and atenolol

Authors: W. Hikiji, K. Kudo, N. Nishida, T. Ishida, Y. Usumoto, A. Tsuji, N. Ikeda

Published in: International Journal of Legal Medicine | Issue 6/2008

Login to get access

Abstract

A fatal case of intentional poisoning with two antiarrhythmic agents, pilsicainide, a pure sodium channel blocker, and atenolol, a selective β1 blocker, is presented. A woman in her twenties was found dead at home and empty pill packages of pilsicainide, atenolol, and aspirin were found near by. Hesitation marks were found on the wrist, and strong fibrous degeneration was observed in the cardiomyocytes of the sinoatrial node. The blood concentrations of pilsicainide and atenolol were 7.83 and 4.94 μg/ml, respectively, both far above the reported therapeutic levels. According to these results, we concluded that death was due to cardiac arrhythmia caused by poisoning with pilsicainide and atenolol. This is the first report of fatal poisoning attributable to an overdose of the combination of these two antiarrhythmic drugs.
Literature
1.
go back to reference Kumagai K, Nakashima H, Tojo H et al (2006) Pilsicainide for atrial fibrillation. Drugs 66:2067–2073PubMedCrossRef Kumagai K, Nakashima H, Tojo H et al (2006) Pilsicainide for atrial fibrillation. Drugs 66:2067–2073PubMedCrossRef
2.
go back to reference Hoffman BB, Lefkowitz RJ (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman LS, Gilman A, Hardman JG, Limbird LE (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 9th edn. McGraw Hill, New York, pp 199–248 Hoffman BB, Lefkowitz RJ (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Goodman LS, Gilman A, Hardman JG, Limbird LE (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 9th edn. McGraw Hill, New York, pp 199–248
3.
go back to reference Nakata K, Moriwaki R, Yamaguchi A, Takenouchi S, Mato T, Tsutsumi H (2006) Case in which magnesium sulfate effectively treated ventricular tachycardia due to overdose of pilsicainide hydrochloride. Chudoku Kenkyu 19:49–53PubMed Nakata K, Moriwaki R, Yamaguchi A, Takenouchi S, Mato T, Tsutsumi H (2006) Case in which magnesium sulfate effectively treated ventricular tachycardia due to overdose of pilsicainide hydrochloride. Chudoku Kenkyu 19:49–53PubMed
4.
go back to reference Horita Y, Kanaya H, Uno Y et al (2004) A case of the toxicity of pilsicainide hydrochloride with comparison of the serial serum pilsicainide levels and electrocardiographic findings. Jpn Heart J 45:1049–1056PubMedCrossRef Horita Y, Kanaya H, Uno Y et al (2004) A case of the toxicity of pilsicainide hydrochloride with comparison of the serial serum pilsicainide levels and electrocardiographic findings. Jpn Heart J 45:1049–1056PubMedCrossRef
5.
go back to reference Ozeki S, Utsunomiya T, Matsuo S, Yano K (1999) Pilsicainide intoxication in a patient with dehydration. Jpn Circ J 63:219–222PubMedCrossRef Ozeki S, Utsunomiya T, Matsuo S, Yano K (1999) Pilsicainide intoxication in a patient with dehydration. Jpn Circ J 63:219–222PubMedCrossRef
6.
go back to reference Petrov D, Sardowski S, Geshava M (2007) ‘Silent’ Prinzmetal’s ST elevation related to atenolol overdose. J Emerg Med 33:123–126PubMedCrossRef Petrov D, Sardowski S, Geshava M (2007) ‘Silent’ Prinzmetal’s ST elevation related to atenolol overdose. J Emerg Med 33:123–126PubMedCrossRef
7.
go back to reference Love JN, Elshami J (2002) Cardiovascular depression resulting from atenolol intoxication. Eur J Emerg Med 9:111–114PubMedCrossRef Love JN, Elshami J (2002) Cardiovascular depression resulting from atenolol intoxication. Eur J Emerg Med 9:111–114PubMedCrossRef
8.
go back to reference Snook CP, Sigvaldason K, Kristinsson J (2000) Severe atenolol and diltiazem overdose. J Toxicol Clin Toxicol 38:661–665PubMedCrossRef Snook CP, Sigvaldason K, Kristinsson J (2000) Severe atenolol and diltiazem overdose. J Toxicol Clin Toxicol 38:661–665PubMedCrossRef
9.
go back to reference Pertoldi F, D’Orlando L, Mercante WP (1998) Electromechanical dissociation 48 hours after atenolol overdose; usefulness of calcium chloride. Ann Emerg Med 31:777–781PubMedCrossRef Pertoldi F, D’Orlando L, Mercante WP (1998) Electromechanical dissociation 48 hours after atenolol overdose; usefulness of calcium chloride. Ann Emerg Med 31:777–781PubMedCrossRef
10.
go back to reference Delima LG, Kharasch ED, Butler S (1995) Successful pharmacologic treatment of massive atenolol overdose: sequential hemodynamics and plasma atenolol concentrations. Anesthesiology 83:204–207PubMedCrossRef Delima LG, Kharasch ED, Butler S (1995) Successful pharmacologic treatment of massive atenolol overdose: sequential hemodynamics and plasma atenolol concentrations. Anesthesiology 83:204–207PubMedCrossRef
11.
go back to reference Stinson J, Walsh M, Feely J (1992) Ventricular asystole and overdose with atenolol. BMJ 305:693PubMed Stinson J, Walsh M, Feely J (1992) Ventricular asystole and overdose with atenolol. BMJ 305:693PubMed
12.
go back to reference Saitz R, Williams BW, Farber HW (1991) Atenolol-induced cardiovascular collapse treated with hemodialysis. Crit Care Med 19:116–118PubMedCrossRef Saitz R, Williams BW, Farber HW (1991) Atenolol-induced cardiovascular collapse treated with hemodialysis. Crit Care Med 19:116–118PubMedCrossRef
13.
go back to reference Abbasi IA, Sorsby S (1986) Prolonged toxicity from atenolol overdose in an adolescent. Clin Pharm 5:836–837PubMed Abbasi IA, Sorsby S (1986) Prolonged toxicity from atenolol overdose in an adolescent. Clin Pharm 5:836–837PubMed
14.
go back to reference Freestone S, Thomas HM, Bhamra RK, Dyson EH (1986) Severe atenolol poisoning: treatment with prenalterol. Hum Toxicol 5:343–345PubMedCrossRef Freestone S, Thomas HM, Bhamra RK, Dyson EH (1986) Severe atenolol poisoning: treatment with prenalterol. Hum Toxicol 5:343–345PubMedCrossRef
15.
go back to reference Weinstein RS, Cole S, Knaster HB, Dalbert T (1985) Beta blocker overdose with propranolol and with atenolol. Ann Emerg Med 14:161–163PubMedCrossRef Weinstein RS, Cole S, Knaster HB, Dalbert T (1985) Beta blocker overdose with propranolol and with atenolol. Ann Emerg Med 14:161–163PubMedCrossRef
16.
go back to reference Montgomery AB, Stager MA, Schoene RB (1985) Marked suppression of ventilation while awake following massive ingestion of atenolol. Chest 88:920–921PubMedCrossRef Montgomery AB, Stager MA, Schoene RB (1985) Marked suppression of ventilation while awake following massive ingestion of atenolol. Chest 88:920–921PubMedCrossRef
17.
go back to reference Ishida T, Kudo K, Inoue H, Tsuji A, Kojima T, Ikeda N (2006) Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography–mass spectrometry. J Anal Tox 30:468–477 Ishida T, Kudo K, Inoue H, Tsuji A, Kojima T, Ikeda N (2006) Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography–mass spectrometry. J Anal Tox 30:468–477
18.
go back to reference Venkatesh G, Ramanathan S, Mansor SM et al (2007) Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies. J Pharm Biomed Anal 43:1546–1551PubMedCrossRef Venkatesh G, Ramanathan S, Mansor SM et al (2007) Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies. J Pharm Biomed Anal 43:1546–1551PubMedCrossRef
19.
go back to reference Drasch G, Dahlmann F, von Meyer L, Roider G, Eisenmenger W (2008) Frequency of different anti-depressants associated with suicides drug deaths. Int J Legal Med 122:115–121PubMedCrossRef Drasch G, Dahlmann F, von Meyer L, Roider G, Eisenmenger W (2008) Frequency of different anti-depressants associated with suicides drug deaths. Int J Legal Med 122:115–121PubMedCrossRef
20.
go back to reference Watson WA, Litovitz TL, Rodgers GC Jr et al (2005) 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23:589–666PubMedCrossRef Watson WA, Litovitz TL, Rodgers GC Jr et al (2005) 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23:589–666PubMedCrossRef
21.
go back to reference Miyano S, Sumoto K, Satoh F et al (1985) New antiarrhythmic agents. N-aryl-8-pyrrolizidinealkamides. J Med Chem 28:714–717PubMedCrossRef Miyano S, Sumoto K, Satoh F et al (1985) New antiarrhythmic agents. N-aryl-8-pyrrolizidinealkamides. J Med Chem 28:714–717PubMedCrossRef
22.
go back to reference Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T (1988) Effects of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles. J Cardiovasc Pharmacol 11:407–412PubMedCrossRef Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T (1988) Effects of SUN 1165, a new potent antiarrhythmic agent, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles. J Cardiovasc Pharmacol 11:407–412PubMedCrossRef
23.
go back to reference Kanki H, Mitamura H, Takatsuki S et al (1998) Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics. Cardiovascular Drugs and Therapy 12:475–482PubMedCrossRef Kanki H, Mitamura H, Takatsuki S et al (1998) Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics. Cardiovascular Drugs and Therapy 12:475–482PubMedCrossRef
24.
go back to reference Satoh S, Watanabe J, Keitoku M et al (1989) Effects of N-(2,6-dimethylphenyl)-8-pyrrolizine acetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathways. Arzneimittel-Forschung Drug Res 39:908–911 Satoh S, Watanabe J, Keitoku M et al (1989) Effects of N-(2,6-dimethylphenyl)-8-pyrrolizine acetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathways. Arzneimittel-Forschung Drug Res 39:908–911
25.
go back to reference Holstege CP, Eldridge DL, Rowden AK (2006) ECG manifestations: the poisoned patient. Emerg Med Clin North Am 24:159–177PubMedCrossRef Holstege CP, Eldridge DL, Rowden AK (2006) ECG manifestations: the poisoned patient. Emerg Med Clin North Am 24:159–177PubMedCrossRef
26.
go back to reference Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP (1996) Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 34:273–278PubMed Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP (1996) Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 34:273–278PubMed
27.
go back to reference Delk C, Holstege CP, Brady WJ (2007) Electrocardiographic abnormalities associated with poisoning. Am J Emerg Med 25:672–687PubMedCrossRef Delk C, Holstege CP, Brady WJ (2007) Electrocardiographic abnormalities associated with poisoning. Am J Emerg Med 25:672–687PubMedCrossRef
28.
go back to reference Moriya F, Hashimoto Y (1999) Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages post-mortem. J Forensic Sci 44:10–16PubMed Moriya F, Hashimoto Y (1999) Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages post-mortem. J Forensic Sci 44:10–16PubMed
29.
go back to reference Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232PubMedCrossRef Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232PubMedCrossRef
31.
go back to reference Ishizaki T, Oyama Y, Suganuma T et al (1983) A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady state pharmacokinetics. Br J Clin Pharmacol 16:17–25PubMed Ishizaki T, Oyama Y, Suganuma T et al (1983) A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady state pharmacokinetics. Br J Clin Pharmacol 16:17–25PubMed
32.
go back to reference Maeno K, Ikeda T, Takada S, Kobayashi K, Bunko H, Hisada K (1990) The effect of oral SUN-1165 on hemodynamics at rest and during exercise in patients with ischemic heart disease. Jpn Pharmacol Ther 18:4051–4057 Maeno K, Ikeda T, Takada S, Kobayashi K, Bunko H, Hisada K (1990) The effect of oral SUN-1165 on hemodynamics at rest and during exercise in patients with ischemic heart disease. Jpn Pharmacol Ther 18:4051–4057
33.
go back to reference Baselt RC (ed.) (2002) Disposition of toxic drugs and chemicals in man, 7th ed. Biomedical Publications, Foster City, CA, pp 87–88 Baselt RC (ed.) (2002) Disposition of toxic drugs and chemicals in man, 7th ed. Biomedical Publications, Foster City, CA, pp 87–88
Metadata
Title
Acute fatal poisoning with pilsicainide and atenolol
Authors
W. Hikiji
K. Kudo
N. Nishida
T. Ishida
Y. Usumoto
A. Tsuji
N. Ikeda
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
International Journal of Legal Medicine / Issue 6/2008
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-008-0269-8

Other articles of this Issue 6/2008

International Journal of Legal Medicine 6/2008 Go to the issue